Mahzi Therapeutics

BiotechnologySeries ASan Mateo, USmahzi.com

Latest round

Series A

Last raised

Oct 2022

Total raised

$51M

Investors

1

About Mahzi Therapeutics

Founded in 2020 and based in California, US, Mahzi Therapeutics Inc. is a healthcare and biotechnology research company that focuses on treating rare genetic neurodevelopmental disorders. In October 2022, Mahzi Therapeutics Inc. The company has expertise in identifying and developing tailored therapeutic approaches for each distinct neurodevelopmental disorder. The firm’s pipeline includes disease identification and understanding, where the initial phase involves comprehensive research to identify, comprehend, and define the specific nuances of each targeted disorder, such as WOREE/SCAR12 (WWOX Deficiency), Pitt Hopkins (TCF4 Deficiency), and CHD2 Deficiency. The firm then undergoes pre-clinical development and conducts pre-clinical studies, employing scientific methodologies to assess the feasibility and efficacy of potential therapeutic interventions. Mahzi then focuses on meeting regulatory requirements and ensuring the safety and efficacy of its prospective treatments before advancing to human trials. Finally, the company initiates human trials to evaluate the safety and efficacy of the developed therapies.

Who invested in Mahzi Therapeutics

1 investor across 2 rounds

See all investors in Mahzi Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Oct 25, 2022

    Amount

    $4M

    Investors

    Locked

  2. Series A

    Oct 7, 2021

    Amount

    $47M

    Investors

    Locked

Questions about Mahzi Therapeutics

Who invested in Mahzi Therapeutics?

Mahzi Therapeutics has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Mahzi Therapeutics raised?

Mahzi Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Mahzi Therapeutics last raise money?

Mahzi Therapeutics's most recent round on record is a Series A, in Oct 2022.

What does Mahzi Therapeutics do?

Founded in 2020 and based in California, US, Mahzi Therapeutics Inc.

Where is Mahzi Therapeutics headquartered?

Mahzi Therapeutics is headquartered in San Mateo, US.

Which VCs invest in companies like Mahzi Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Mahzi Therapeutics's stage. Their profiles are linked below.

Raising like Mahzi Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.